Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Journal of Comparative Effectiveness Research|March 3, 2015
Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020Donna A Messner, Penny Mohr, Adrian Towse
Health Research Policy and Systems|September 4, 2015
Government and charity funding of cancer research: public preferences and choicesKoonal Kirit Shah, Jon Sussex, Karla Hernandez-Villafuerte
Journal of Health Services Research & Policy|April 5, 2007
Prioritizing health technologies in a Primary Care TrustEdward Wilson, Jon Sussex, Christine Macleod, et al.
Journal of Health Services Research & Policy|July 27, 2004
Influencing prescribing in English primary care: the views of primary care organisationsAnne Mason, Michael Drummond, Adrian Towse, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness AnalysisLouis P Garrison, Sachin Kamal-Bahl, Adrian Towse
International Journal of Technology Assessment in Health Care|March 17, 2022
Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of "Failed" R&D EffortsRichard Z Xie, Adrian Towse, Louis P Garrison
Health Research Policy and Systems|June 10, 2020
From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons?Stephen R Hanney, Steven Wooding, Jon Sussex, et al.
Health Affairs (Project Hope)|May 9, 2007
Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysisLouis P Garrison, Adrian Towse, Brian W Bresnahan
The Lancet. Microbe|June 17, 2024
Implementing an EU pull incentive for antimicrobial innovation and access: blueprint for actionMichael Anderson, Adrian Towse, Kevin Outterson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2022
Why We Need a New Outcomes-Based Value Attribution Framework for Combination Regimens in OncologyAdrian Towse, Mickael Lothgren, Lotte Steuten, et al.
Pageof 11